Technical Analysis for BNIKF - Benitec Ltd

Grade Last Price % Change Price Change
grade F 0.038 -2.56% -0.0010
BNIKF closed down 2.56 percent on Friday, August 2, 2019, on 2 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical BNIKF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -2.56%
Wide Bands Range Expansion -2.56%
Gapped Up Strength -2.56%
Oversold Stochastic Weakness -2.56%
New 52 Week Closing Low Bearish 11.44%
Narrow Range Bar Range Contraction 11.44%
New 52 Week Low Weakness 11.44%

Older signals for BNIKF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing therapy, DNA-directed RNA interference (ddRNAi) in Australia and the United States. The company provides BB-301, a single administration ddRNAi-based gene therapy for the treatment of oculopharyngeal muscular dystrophy; BB-201, a ddRNAi-based therapy for the treatment of wet age-related macular degeneration; and BB-101 and BB-103 ddRNAi-based therapies for the treatment of human hepatitis B. It also offers BB-401 and BB-501 for the treatment of oncology related to head and neck squamous cell carcinoma. The company was founded in 1995 and is headquartered in North Sydney, Australia.
Biotechnology RTT Branches Of Biology Life Sciences Biology Gene Therapy Macular Degeneration Muscular Dystrophy Wet Age Related Macular Degeneration Genetic Engineering Rna Interference Applied Genetics
Is BNIKF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 0.26
52 Week Low 0.0341
Average Volume 22,633
200-Day Moving Average 0.1149
50-Day Moving Average 0.0784
20-Day Moving Average 0.0542
10-Day Moving Average 0.0386
Average True Range 0.0052
ADX 29.64
+DI 26.2136
-DI 53.3981
Chandelier Exit (Long, 3 ATRs ) 0.0814
Chandelier Exit (Short, 3 ATRs ) 0.0497
Upper Bollinger Band 0.0975
Lower Bollinger Band 0.0109
Percent B (%b) 0.31
BandWidth 159.778598
MACD Line -0.0139
MACD Signal Line -0.0137
MACD Histogram -0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0380
Resistance 3 (R3) 0.0380 0.0380 0.0380
Resistance 2 (R2) 0.0380 0.0380 0.0380 0.0380
Resistance 1 (R1) 0.0380 0.0380 0.0380 0.0380 0.0380
Pivot Point 0.0380 0.0380 0.0380 0.0380 0.0380
Support 1 (S1) 0.0380 0.0380 0.0380 0.0380 0.0380
Support 2 (S2) 0.0380 0.0380 0.0380 0.0380
Support 3 (S3) 0.0380 0.0380 0.0380
Support 4 (S4) 0.0380